(Q48295399)

10 February 2018

title

Cardioembolic caudate infarction as a cause of hemichorea in lupus anticoagulant syndrome (English)

1 reference

10 February 2018

1 reference

1 reference

Kirk A

1

1 reference

10 February 2018

Harding SR

series ordinal

2

1 reference

10 February 2018

publication date

1 May 1993

1 reference

10 February 2018

Canadian Journal of Neurological Sciences

published in

1 reference

10 February 2018

volume

20

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

162-164

1 reference

10 February 2018

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Cerebrovascular ischemia associated with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Chorea and systemic lupus erythematosus. A critical review

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Cardiogenic brain embolism and lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Neurological disease associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Retinal migraine, chorea, and retinal artery thrombosis in a patient with primary antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

Chorea and bacterial endocarditis.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100047764

7 January 2021

10.1017/S0317167100047764

Identifiers

DOI

0 references

1 reference

10 February 2018